Get startedLog in
    Picture of Disruptive Pharma AB (publ) logo

    DPHA — Disruptive Pharma AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Guard Therapeutics International: Positive Interim Results From Phase 1 Study Of ROSgard

    Picture of Disruptive Pharma AB (publ) logoDisruptive Pharma AB (publ)
    10/08/2020 10:22
    Aug 10 (Reuters) - Guard Therapeutics International AB
(publ)  GUARD.ST :
    * REPORTS POSITIVE INTERIM RESULTS FROM PHASE 1 STUDY OF
ROSGARD
IN PATIENTS WITH RENAL IMPAIRMENT

Source text for Eikon:  ID:nNDL3jl0Jd 
Further company coverage:  GUARD.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

    Recent news on Disruptive Pharma AB (publ)

    See all news